Finance

Beta
Lists
018680:KOSDAQ
Seoul Pharma Co Ltd
₩2,170.00
-1.36%
(-30.00) 1D
Jun 10, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 018680...
Open
₩2,310
High
₩2,310
Low
₩2,115
Mkt. cap
25.30B
Avg. vol.
10.67K
Volume
4.82K
P/E ratio
34.85
52-wk high
₩3,595
52-wk low
₩2,030
EPS
₩62
Shares outstanding
11.66M
No. of employees
133
Open
₩2,310
High
₩2,310
Low
₩2,115
Mkt. cap
25.30B
Avg. vol.
10.67K
Volume
4.82K
P/E ratio
34.85
52-wk high
₩3,595
52-wk low
₩2,030
EPS
₩62
Shares outstanding
11.66M
No. of employees
133
News stories
From sources across the web
About Seoul Pharma Co Ltd
CEO-
Employees133
Founded1976
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
12.01B
13.64B
13.61B
12.07B
Cost of goods sold
4.27B
5.60B
5.71B
4.86B
Cost of revenue
4.27B
5.60B
5.71B
4.86B
Research and development expenses
-
-
2.75B
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.66B
8.08B
4.55B
7.39B
Operating expense
8.66B
8.08B
8.12B
7.39B
Total operating expenses
12.92B
13.68B
13.82B
12.25B
Operating income
-913.65M
-33.60M
-217.40M
-185.71M
Other non operating income
-413.83M
2.67B
69.61M
48.55M
EBT including unusual items
-1.33B
2.63B
-492.98M
-137.16M
EBT excluding unusual items
-1.33B
2.63B
-491.20M
-137.16M
Income tax expense
3.23M
9.73M
-117.36M
54.79M
Effective tax rate
-0.24%
0.37%
23.81%
-39.94%
Other operating expenses
-
-
-
-
Net income
-1.33B
2.62B
-375.62M
-191.95M
Net profit margin
-11.08%
19.24%
-2.76%
-1.59%
Earnings per share
-
-
-
-
Interest and investment income
-
-
229.41M
-
Interest expense
-
-
-577.30M
-
Net interest expenses
-
-
-347.88M
-
Depreciation and amortization charges
-
-
761.85M
-
EBITDA
-246.34M
640.30M
435.79M
483.10M
Gain or loss from assets sale
-125.00K
-
1.90M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more